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ABSTRACT
Mounting evidence suggests that malignant tumors
are initiated and maintained by a subpopulation of
cancerous cells with biological properties similar
to those of normal stem cells. However, descrip-
tions of stem-like gene and pathway signatures in
cancers are inconsistent across experimental
systems. Driven by a need to improve our under-
standing of molecular processes that are common
and unique across cancer stem cells (CSCs), we
have developed the Stem Cell Discovery Engine
(SCDE)—an online database of curated CSC experi-
ments coupled to the Galaxy analytical framework.
The SCDE allows users to consistently describe,
share and compare CSC data at the gene and
pathway level. Our initial focus has been on carefully
curating tissue and cancer stem cell-related experi-
ments from blood, intestine and brain to create
a high quality resource containing 53 public
studies and 1098 assays. The experimental informa-
tion is captured and stored in the multi-omics
Investigation/Study/Assay (ISA-Tab) format and
can be queried in the data repository. A linked
Galaxy framework provides a comprehensive,
flexible environment populated with novel tools for
gene list comparisons against molecular signatures
in GeneSigDB and MSigDB, curated experiments in
the SCDE and pathways in WikiPathways. The SCDE
is available at http://discovery.hsci.harvard.edu.
INTRODUCTION
Cells in adult non-germinal tissues such as blood, skin and
intestine turn over briskly and are known to require stem
cells for lifelong renewal. These tissue stem cells are
capable of proliferation and self-renewal, and can
produce differentiated progeny through the expression of
tissue-speciﬁc genes. Recent evidence suggests that
studying adult stem cells can provide insight into cancer
cell biology. Only small fractions of tumor-derived cells
are clonogenic in culture or tumorigenic in vivo (1,2).
Cancers are therefore thought to rely on the activity of
stem or stem-like cells that are tumorigenic and exhibit the
cardinal properties of self-renewal and multi-lineage dif-
ferentiation potential.
Stem and differentiated cells within a tumor are
reported to differ in sensitivity toward therapy (3).
Studies have independently established embryonic stem
cell gene expression signatures where cancer subtypes
with poor survival prognosis are enriched in treatment-
resistant, stem-like cells. Stem cell signatures resulting in
poor prognosis have so far been found in glioma, breast,
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stem cell populations therefore has the potential to
identify new molecular targets for drug and immune
therapies that destroy the self-renewing cancer stem cells
(CSCs). However, descriptions of gene and pathway
stem-like signatures across cancers are inconsistent
across platforms, tissues and laboratories.
Driven by a need to understand CSC molecular proﬁles
generated at the Harvard Stem Cell Institute (HSCI), we
have developed a platform to integrate CSC experimental
information: the Stem Cell Discovery Engine (http://dis-
covery.hsci.harvard.edu). We have collected, curated and
integrated this data into the Stem Cell Discovery Engine
(SCDE) to permit molecular comparisons between normal
and cancerous stem cells, between stem-cell compartments
in blood, intestine and brain, and between mouse models
and human tissues.
SCDE overview
The SCDE is a modular online system designed to handle
data submission, curation, analysis, integration and dis-
semination of stem cell-related experiments (Figure 1).
The system has two components: (i) a tissue and cancer
stem cell database accessible through the BioInvestigation
Index (BII) (11) and (ii) a customized instance of the
Galaxy analysis engine (12,13). It includes tools that inte-
grate public stem cell data with user-submitted experi-
ments. Its initial focus is on gene list manipulation, and
interaction with the curated Gene Signatures Database
(GeneSigDB) (14), Molecular Signatures Database
(MSigDB) (15), and WikiPathways pathway database
(16)( Figure 1). A description of the database in accord-
ance with BioDBCore standards (17) is available in
Supplementary Table S1.
Curation of experimental metadata and derived data
The SCDE database provides a source of structured ex-
perimental information on assays, derived gene lists and
pathway proﬁles. Heterogeneity in experimental informa-
tion has been reduced by rigorous, manual curation of the
experimental model, cell and tissue types, disease state,
surface markers and other relevant data. Submitted user
data is ﬁrst checked for relevance, i.e. studies must be
performed using well-deﬁned stem cell, tissue stem cell
and/or cancer stem cell populations, and must produce
genome-scale data with potential to provide insight into
the stem-like characteristics of cancers. All of the raw data
with its sample characteristics must be available. Data
input ﬁelds are then mapped to the ontologies listed in
Table 1 according to species-speciﬁcity and overall
coverage of the ontology. New terms are submitted to
the ontology maintainers for future inclusion. This
ensures that new terms are standardized and incorporated
for community use. Experimental protocols and analytical
methods are annotated with the goal of providing sufﬁ-
cient information to reproduce or perform similar experi-
ments and to derive the processed data. Derived data in
the form of gene lists are converted to standardized iden-
tiﬁers to be used for gene list comparisons within Galaxy.
We stored experimental metadata in the Investigation/
Study/Assay (ISA-Tab) format, i.e. high level information
about the experiment is recorded in the ‘investigation’ ﬁle,
sample attributes and factors in the ‘study’ ﬁles, and
protocols and analysis methods in the ‘assay’ ﬁles.
This general purpose tab-delimited grammar manages
metadata from diverse studies, and enables users to align
with community-deﬁned minimum information, onto-
logies and checklists (11,18,19). It comes with support
tools for curation (including semi-automated annotation
tagging through the NCBO BioPortal annotation service
(20) to speed the process) and format conversion (http://
isatab.sourceforge.net) to make it straightforward to
submit data to international public repositories, such as
the Gene Expression Omnibus (GEO) (21). ISA-Tab is
supported and maintained by a global collaboration of
biocurators (22). While the initial cost of curation is
high, it allows for sharing of ISA-Tab conﬁgurations we
have developed speciﬁcally for stem cell data that can be
used within the various ISA tools by the stem cell com-
munity. The goal is to build a curation network and es-
tablish community involvement so that standards are
agreed upon and adopted.
Database contents
A primary focus was a selection of studies related to
normal and CSCs, and in particular for three model
systems—blood, intestine and brain. In these tissues, the
behavior of native stem cells is especially well
characterized, investigators generally agree on stem cell
deﬁnitions, and cancer is common. Table 2 shows the dis-
tribution of data across organisms, tissues and types of
measurements. The database integrates 53 public studies
comprised of 1098 molecular assays from CSC-related ex-
periments from multiple tissues, species and heteroge-
neous platforms. Five additional studies comprised of 84
assays are stored as private, unpublished data that are
available to speciﬁc researchers upon login and are
ready for dissemination upon publication. Fifteen
studies were contributed by researchers in the HSCI com-
munity and an additional 40 studies related to CSC
biology were selected from StemBase (23,24). Forty-six
studies were performed in rodent models and 13 in
human cells; these include two studies containing
samples assayed from both rodent and human models.
The database is made up in large part by microarray ex-
pression proﬁling studies but results from nucleotide
sequencing (i.e. ChIP-seq) studies of histone methylation
and transcription factor binding, histology and expression
analysis by RT–PCR are also included.
Data acquisition and dissemination
Researchers can submit their own data or suggest public
data to a curator, who manually curates it according to
community-accepted standards and ontologies (Table 1).
In cases where published studies have associated data de-
posited in ArrayExpress, the MAGEtoISA converter tool
permits rapid conversion from MAGE-TAB to ISA-Tab
format, which is then manually evaluated by a curator for
completeness and corrected where necessary.
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Figure 1. System architecture diagram showing integration of data into the SCDE BioInvestigation Index (BII) and Galaxy instances. CSC-related
experiments are submitted by stem cell researchers or selected from public repositories. After curation using the ISA tools and conversion to ISA-Tab
format, the associated metadata, raw data ﬁles and processed gene lists are stored in the BII. The stem cell-speciﬁc gene lists are transformed into
standardized gene identiﬁers to facilitate integration and comparison against similarly formatted reference lists (GeneSigDB, MSigDB, WikiPathways
and other SCDE experiments) within Galaxy.
Table 1. Curated metadata
Field Ontologies (in order of preference)
Organism NEWT UniProt Taxonomy Database (Newt), NCBI Taxonomy (NCBITaxon)
Strain Experimental Factor Ontology (EFO)
Developmental stage EFO
Disease state ICD-9, NCI Thesaurus, Disease Ontology
Organism part (tissue type) Foundational Model of Anatomy, Mouse Gross Anatomy, BRENDA tissue/enzyme source (BTO), EFO
Cell type Cell Type Ontology (CL), EFO
Cell line EFO, NCI Thesaurus
Genotype Ontology for Biomedical Investigations (OBI; depending on species)
Cell surface marker Currently annotated as ±, high/lo. An appropriate standard needs to be developed.
Immunoprecipitation antibody Protein Name (specify manufacturer where available)
Binding site SO (sequence ontology) for methylation sites
Phenotypic quality PATO: Phenotypic qualities (properties)
Treatment (perturbation) PATO, CHEBI: Chemical Entities of Biological Interest OBI (to describe perturbations such as
genetic modiﬁcation, transient expression)
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and derived data sets are organized in a standardized
manner and disseminated to the public using a local
instance of the SCDE Bioinvestigation Index (BII). This
data repository is designed to support storage, querying
and display of multi-omics data sets (11). The annotated
metadata allows users to search the entire corpus of ex-
periments in the BII based on organism, measurement
type (e.g. transcriptional proﬁling), technology (e.g. nu-
cleotide sequencing), and platform (e.g. Illumina) or to
search free text across all ﬁelds (Figure 2A). Study pages
display the details of each experiment (Figure 2B–D). The
annotation has focused on ensuring that cell types, tissues
and experimental variables are consistently reported to
improve query capabilities, and to establish sound anno-
tation practices to describe stem cell research (e.g. descrip-
tions of genetic modiﬁcations).
Published studies are automatically made publicly avail-
able. ISA-Tab formatted metadata can be downloaded
for information pertaining to the assays, such as normal-
ization procedures for microarray experiments and GEO
accession identiﬁers where available. Raw primary data
(e.g. CEL ﬁles for Affymetrix microarrays) and processed
derived data (e.g. author-generated gene lists) can also be
downloaded from the BII using the ‘Raw Data’ and
‘Processed Data’ buttons (Figure 2E). Alternatively, the
data can be accessed within the SCDE Galaxy framework
for analysis as described in the following section.
Researchers with the appropriate access permissions can
query unpublished data to perform early analyses, and
upon publication, have the added beneﬁt of exporting
their ISA-Tab formatted data for submission to
ArrayExpress using the conversion tools. The correspond-
ing functionality for submission to GEO in MiniML
format is in progress and will represent a valuable incen-
tive for the stem cell community to use the SCDE as a ﬁrst
port of call for submission of CSC functional genomics
data.
Querying CSC molecular signatures using Galaxy
In addition to querying experimental metadata, the SCDE
provides functionality to interrogate stem cell molecular
proﬁles in a linked Galaxy instance, with the goal of iden-
tifying similarities and differences between normal and
cancer stem cell experiments. All raw and processed data
stored in the BII and several additional manually curated
stem cell-related gene lists are accessible from within
Galaxy for analysis.
Manual curation and consistent identiﬁer conver-
sion differentiate the SCDE from other gene list compari-
son tools. Derived gene lists have been mapped to
standardized gene symbols using methods developed for
GeneSigDB. Such standardization allows for comparisons
to determine genes that are shared or unique across
experiments. Tools are available to compare a single
gene list (SCDE ListMatch) or multiple gene lists
(SCDE ListCompare) against curated gene signatures in
GeneSigDB, molecular signatures in MSigDB, derived
gene lists from the SCDE database and pathways
in WikiPathways. These tools allow users to identify
genes in common with deﬁned reference signatures
and pathways (Figure 3). Results are summarized and
ranked according to a hypergeometric test P-value and
linked to the relevant overlapping gene sets (Figure 3B).
For WikiPathways comparisons, a link is provided to
visualize the gene matches in color-coded diagrams of ca-
nonical pathways (Figure 3C). The SCDE Intersect tool
identiﬁes genes that are common to multiple gene lists. By
using the Galaxy interface, users can maintain a record of
their analysis history and easily compare multiple data sets
stored in their history.
DISCUSSION
The SCDE database provides a repository for curated
CSC data and a framework for developing methods to
compare molecular information on stem cell related popu-
lations. We illustrate the functionality of the SCDE using
the following use case as an example. A leukemia research-
er enters the SCDE through the BII interface. A search for
the term ‘leukemia’ in the free text search box produces
ﬁve transcriptional proﬁling studies performed in mouse
models. The user selects the ﬁrst result (ARMSTRONG-
S-1) to obtain further details of the study and is provided
with information about genetic modiﬁcations, hematopoi-
etic progenitor cell types, immunophenotypes, type
of leukemia studied and the mouse strain used in the ex-
periment. Wishing to perform a related experiment, the
researcher downloads the experimental metadata in
ISA-Tab format, which provides him with additional in-
formation about the sample cell types, labeling protocol,
microarray chip used, number of replicates, normalization
procedure, etc. After performing his experiment, the re-
searcher returns to the SCDE to determine how similar his
results are to the ARMSTRONG-S-1 study, or indeed to
any of the experiments in the SCDE. Using the Galaxy
web interface, he uploads his list of differentially expressed
genes from his leukemia experiment and uses the
ListMatch tool to determine the following: (i) signiﬁcant
Table 2. SCDE data
Studies
a Assays
a
Organism
Mouse 45 (4) 846 (54)
Human 13 (1) 255 (30)
Rat 1 18
Tissue type
Blood/bone marrow 20 (3) 374 (48)
Muscle 8 125
Brain/neural 6 (1) 68 (6)
Intestine 4 39
Mammary 2 34
Skin 2 (1) 135 (30)
Measurement
b
Transcription proﬁling 57 (5) 1161 (84)
Histone modiﬁcation proﬁling 2 42
Transcription factor binding site identiﬁcation 1 21
Tissue histology 1 (1) 6 (6)
aTotal number of studies and assays; the number of private studies and
assays are shown in brackets
bFurther information and details of technology platforms are available
online at http://discovery.hsci.harvard.edu.
Nucleic Acids Research, 2012,Vol.40, Database issue D987Figure 2. Screenshots showing elements of the BioInvestigation Index browse view. (A) The results of a free text search using the term ‘intestine’ that
retrieves four studies—two human and two murine—that include transcription proﬁling using DNA microarrays, and ChIP-seq for transcription
factor binding and histone modiﬁcations; (B) One matching record, SHIVDASANI-S-1, with descriptive text; (C) Annotated experimental factor
metadata including time, antibodies used in the chromatin immunoprecipitation (ChIP) experiments, and cell differentiation status; (D) Annotated
sample metadata including the tissue and cell types, using the Foundational Model of Anatomy (FMA) and Brenda Tissue (BTO) ontologies,
respectively; (E) Download panel for the raw and processed data.
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may reveal similarities to the leukemia studies or other
hematopoietic stem cell experiments contained in the
SCDE; (ii) genes enriched in curated signatures from
GeneSigDB or mSigDB (such overlaps provide informa-
tion about similar diseases states, positional biases and
functional groupings) and (iii) genes that overlap with
known pathways from WikiPathways (genes are projected
onto the canonical pathway diagram to indicate where
they occur within the pathway). Going a step further,
the researcher uses the ListCompare tool to ﬁnd the
overlap with the ARMSTRONG-S-1 gene list with
reference to canonical pathways in WikiPathways. This
allows him to identify pathways that contain genes from
both lists even where the intersection of the two lists is
small, generating hypotheses about possible pathways to
study further. Having done his analysis within Galaxy, the
researcher saves the gene lists, parameters and results and
can share this data with his collaborators or make it
publicly available.
The SCDE is unique in its community-oriented
approach for identifying relevant experiments, capturing
and curating study information, and integrating new
analysis capabilities compared to previous resources. The
Figure 3. Composite ﬁgure showing the results of a ListMatch query using the set of intestinal differentiation genes that are reduced upon Cdx2
depletion from the SHIVDASANI-S-2 study. (A) SCDE ListMatch input page with options to compare against WikiPathways, GeneSigDB,
MSigDB and the SCDE repository. (B) Results of the query against WikiPathways projected onto the canonical pathway representation with
matching genes highlighted in red (partial screenshot shown). (C) Querying against GeneSigDB results in a top match to genes related to liver cancer.
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multiple diverse data types and demonstrates that the
tools we have used are ready for scale up. The Galaxy
framework allows us to rapidly add relevant analysis
methods developed by the growing Galaxy development
community in which we are active participants. The im-
plementation of open source software projects that are
gaining community support will ensure that the SCDE
continues to evolve. The tools developed for the SCDE
Galaxy instance have been published on bitbucket at the
URL http://bitbucket.org/hbc/galaxy-central-hbc. By
publishing this resource and making the infrastructure
available, we hope to develop the stem cell community
and obtain feedback on annotation practices, relevant
data sets and analytical methods.
Future directions
While the comparison of gene signatures is informative, a
systematic approach to compare and determine the role of
key pathway contributions across different experimental
systems and cancers against a consistent background is
needed. A pathway ﬁngerprinting method to determine
functional similarity among experiments independently
of platform or species is being developed for integration
into the SCDE (Altschuler et al., submitted). We will
continue to expand the SCDE to include additional
CSC-related studies and new data types, and work with
the stem cell community to further reﬁne relevant ontology
terms, as has been the case for the Cell Ontology (25). A
further focus will be to develop methods to integrate epi-
genetic data with gene expression. Scientists interested in
adding or curating studies, or in implementing analysis
options that are not yet available, are encouraged to
contact us at scde@hsci.harvard.edu.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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